188 related articles for article (PubMed ID: 22065568)
1. Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer.
Lindén M; Lind SB; Mayrhofer C; Segersten U; Wester K; Lyutvinskiy Y; Zubarev R; Malmström PU; Pettersson U
Proteomics; 2012 Jan; 12(1):135-44. PubMed ID: 22065568
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancer.
Urquidi V; Goodison S; Ross S; Chang M; Dai Y; Rosser CJ
J Urol; 2012 Dec; 188(6):2377-83. PubMed ID: 23088986
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Apo-A1 as a potential bladder cancer biomarker by urine proteomics and analysis.
Li C; Li H; Zhang T; Li J; Liu L; Chang J
Biochem Biophys Res Commun; 2014 Apr; 446(4):1047-52. PubMed ID: 24661883
[TBL] [Abstract][Full Text] [Related]
4. Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification.
Yang N; Feng S; Shedden K; Xie X; Liu Y; Rosser CJ; Lubman DM; Goodison S
Clin Cancer Res; 2011 May; 17(10):3349-59. PubMed ID: 21459797
[TBL] [Abstract][Full Text] [Related]
5. FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.
Beukers W; van der Keur KA; Kandimalla R; Vergouwe Y; Steyerberg EW; Boormans JL; Jensen JB; Lorente JA; Real FX; Segersten U; Orntoft TF; Malats N; Malmström PU; Dyrskjot L; Zwarthoff EC
J Urol; 2017 Jun; 197(6):1410-1418. PubMed ID: 28049011
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic role of urinary collagens in primary human bladder cancer.
Miyake M; Morizawa Y; Hori S; Tatsumi Y; Onishi S; Owari T; Iida K; Onishi K; Gotoh D; Nakai Y; Anai S; Chihara Y; Torimoto K; Aoki K; Tanaka N; Shimada K; Konishi N; Fujimoto K
Cancer Sci; 2017 Nov; 108(11):2221-2228. PubMed ID: 28837258
[TBL] [Abstract][Full Text] [Related]
7. Re: Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancer: V. Urquidi, S. Goodison, S. Ross, M. Chang, Y. Dai and C. J. Rosser. J Urol 2012; 188: 2377-2383.
Dizdar O; Rahatli S; Ozcan MF
J Urol; 2013 Jun; 189(6):2394. PubMed ID: 23321579
[No Abstract] [Full Text] [Related]
8. A multi-analyte assay for the non-invasive detection of bladder cancer.
Goodison S; Chang M; Dai Y; Urquidi V; Rosser CJ
PLoS One; 2012; 7(10):e47469. PubMed ID: 23094052
[TBL] [Abstract][Full Text] [Related]
9. UBC
Ecke TH; Weiß S; Stephan C; Hallmann S; Barski D; Otto T; Gerullis H
Tumour Biol; 2017 May; 39(5):1010428317701624. PubMed ID: 28468590
[TBL] [Abstract][Full Text] [Related]
10. Reply by authors.
J Urol; 2013 Jun; 189(6):2394-5. PubMed ID: 23805426
[No Abstract] [Full Text] [Related]
11. Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine.
Kageyama S; Isono T; Iwaki H; Wakabayashi Y; Okada Y; Kontani K; Yoshimura K; Terai A; Arai Y; Yoshiki T
Clin Chem; 2004 May; 50(5):857-66. PubMed ID: 14764641
[TBL] [Abstract][Full Text] [Related]
12. Profilin 1 is a potential biomarker for bladder cancer aggressiveness.
Zoidakis J; Makridakis M; Zerefos PG; Bitsika V; Esteban S; Frantzi M; Stravodimos K; Anagnou NP; Roubelakis MG; Sanchez-Carbayo M; Vlahou A
Mol Cell Proteomics; 2012 Apr; 11(4):M111.009449. PubMed ID: 22159600
[TBL] [Abstract][Full Text] [Related]
13. Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling.
Kreunin P; Zhao J; Rosser C; Urquidi V; Lubman DM; Goodison S
J Proteome Res; 2007 Jul; 6(7):2631-9. PubMed ID: 17518487
[TBL] [Abstract][Full Text] [Related]
14. FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.
Blanca A; Requena MJ; Alvarez J; Cheng L; Montironi R; Raspollini MR; Reymundo C; Lopez-Beltran A
Biomark Med; 2016; 10(3):243-53. PubMed ID: 26861974
[TBL] [Abstract][Full Text] [Related]
15. Identification of urine PLK2 as a marker of bladder tumors by proteomic analysis.
Tan LB; Chen KT; Yuan YC; Liao PC; Guo HR
World J Urol; 2010 Feb; 28(1):117-22. PubMed ID: 19506885
[TBL] [Abstract][Full Text] [Related]
16. Novel urinary biomarkers ADXBLADDER and bladder EpiCheck for diagnostics of bladder cancer: A review.
Wolfs JRE; Hermans TJN; Koldewijn EL; van de Kerkhof D
Urol Oncol; 2021 Mar; 39(3):161-170. PubMed ID: 33376063
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics.
Chen CL; Lin TS; Tsai CH; Wu CC; Chung T; Chien KY; Wu M; Chang YS; Yu JS; Chen YT
J Proteomics; 2013 Jun; 85():28-43. PubMed ID: 23631828
[TBL] [Abstract][Full Text] [Related]
18. Discovery of potential bladder cancer biomarkers by comparative urine proteomics and analysis.
Lei T; Zhao X; Jin S; Meng Q; Zhou H; Zhang M
Clin Genitourin Cancer; 2013 Mar; 11(1):56-62. PubMed ID: 22982111
[TBL] [Abstract][Full Text] [Related]
19. Bikunin loss in urine as useful marker for bladder carcinoma.
Tsui KH; Tang P; Lin CY; Chang PL; Chang CH; Yung BY
J Urol; 2010 Jan; 183(1):339-44. PubMed ID: 19914646
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Investigation toward the Indicative Proteins of Bladder Cancer in Urine: From Surveying Cell Secretomes to Verifying Urine Proteins.
Guo J; Ren Y; Hou G; Wen B; Xian F; Chen Z; Cui P; Xie Y; Zi J; Lin L; Wu S; Li Z; Wu L; Lou X; Liu S
J Proteome Res; 2016 Jul; 15(7):2164-77. PubMed ID: 27265680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]